Home

Friday, July 21, 2017 - 14:28
Last Saturday, Biolage introduced the new R.A.W. Styling products to consumers at the Wanderlust 108 Festival in Denver in partnership with five local influencers!
http://www.thecoloristmag.com/biolage-raw-gets-buzz-for-new-naked-stylers-at-wanderlust-108
Thursday, July 20, 2017 - 12:04
Absorbable facial suspension sutures made of poly-l-actic acid (PLLA) and poly-lactide-co-glycolide (PGLA) offer benefits to patients with moderate facial aging who require more correction than can be achieved with injectable soft tissue fillers, according to an evidence review of suture lift technologies published in the Journal of Drugs in Dermatology (July 2017).
http://medestheticsmag.com/expert-consensus-absorbable-facial-suspension-sutures
Thursday, July 20, 2017 - 12:04
Absorbable facial suspension sutures made of poly-l-actic acid (PLLA) and poly-lactide-co-glycolide (PGLA) offer benefits to patients with moderate facial aging who require more correction than can be achieved with injectable soft tissue fillers, according to an evidence review of suture lift technologies published in the Journal of Drugs in Dermatology (July 2017).
http://medestheticsmag.com/expert-consensus-absorbable-facial-suspension-sutures

Advertisement - Box 1

Advertisement - Box 2

Thursday, July 20, 2017 - 12:02
Ariel E. Eber, MD, et al, from the University of Miami Miller School of Medicine, conducted a follow-up to a 2014 study that evaluated 472 sunscreens available at two major U.S. retailers (WalMart and Walgreens) to see if they met the American Academy of Dermatology’s recommendations. Dr. Eber and colleagues found that, in 2017, more sunscreens complied with the AAD’s recommendations than in 2014. The recommendations, which were released following the U.S. FDA’s 2011 standardization of sunscreen labeling, include:
http://medestheticsmag.com/majority-sunscreens-distributed-major-us-retailers-meet-aad-recommendations
Thursday, July 20, 2017 - 12:02
Ariel E. Eber, MD, et al, from the University of Miami Miller School of Medicine, conducted a follow-up to a 2014 study that evaluated 472 sunscreens available at two major U.S. retailers (WalMart and Walgreens) to see if they met the American Academy of Dermatology’s recommendations. Dr. Eber and colleagues found that, in 2017, more sunscreens complied with the AAD’s recommendations than in 2014. The recommendations, which were released following the U.S. FDA’s 2011 standardization of sunscreen labeling, include:
http://medestheticsmag.com/majority-sunscreens-distributed-major-us-retailers-meet-aad-recommendations
Thursday, July 20, 2017 - 11:57
Valeant Pharmaceuticals has entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I. Valeant will use proceeds from the sale to permanently repay term loan debt under its Senior Secured Credit Facility. The transaction is expected to close in the second half of 2017, subject to customary closing conditions, including receipt of applicable regulatory approvals.
http://medestheticsmag.com/valeant-sell-obagi-medical-products

Advertisement - Box 3

Advertisement - Box 4

Thursday, July 13, 2017 - 12:58
Wendy Roberts, MD, has developed a devoted following by helping her patients maintain and improve their skin health from head to toe.By Shelley Moench-Kelly, MBAWhen Wendy Roberts, MD, applied to Sarah Lawrence College in New York, a career in medicine was far from her mind. “I was going to major in dance,” she says. “I danced for the Dance Theatre of Harlem and the Garden State Ballet.”
http://medestheticsmag.com/oasis-desert
Thursday, July 13, 2017 - 12:50
Allergan Chairman and CEO Brent Saunders authored a blog post from the CEO on the company’s website in which he shared his concern and discomfort with the growing number of minors undergoing cosmetic enhancement. In the post, he encouraged the medical aesthetics industry to start a dialogue on this topic in an effort to find consensus and provide guidelines for the treatment of minors. Following is Saunder’s post in full:
http://medestheticsmag.com/allergan-ceo-questions-medical-aesthetic-treatment-minors
Thursday, July 13, 2017 - 12:50
Allergan Chairman and CEO Brent Saunders authored a blog post from the CEO on the company’s website in which he shared his concern and discomfort with the growing number of minors undergoing cosmetic enhancement. In the post, he encouraged the medical aesthetics industry to start a dialogue on this topic in an effort to find consensus and provide guidelines for the treatment of minors. Following is Saunder’s post in full:
http://medestheticsmag.com/allergan-ceo-questions-medical-aesthetic-treatment-minors

Pages

Advertisement - Box 5

Advertisement - Box 6